Literature DB >> 24704970

Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).

Hellen Thais Fuzii1, George Alberto da Silva Dias1, Rodrigo Jose Saraiva de Barros1, Luiz Fabio Magno Falcão2, Juarez Antonio Simoes Quaresma3.   

Abstract

Human T-cell lymphotropic virus type 1 (HTLV-1) is associated with adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Only a limited percentage of infected individuals develop disease in response to the virus while the majority remain asymptomatic, and HAM/TSP is the most common clinical manifestation of the virus. HAM/TSP is an inflammatory disease of the central nervous system (CNS); however, the mechanism by which HTLV-1 induces HAM/TSP is not yet clear. CD4(+) T lymphocytes are the main reservoirs of HTLV-1 in vivo and perform an important role in the immunological response to this retrovirus. This virus-host interaction may provoke changes in the immunological response, such as the enhanced production of inflammatory cytokines and the spontaneous proliferation of T CD4(+) lymphocytes, which are implicated in the pathogenesis of HAM/TSP.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical aspects; HTLV; Immunology; Immunopathology

Mesh:

Substances:

Year:  2014        PMID: 24704970     DOI: 10.1016/j.lfs.2014.03.025

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  17 in total

1.  HTLV-1 Infection and Neuropathogenesis in the Context of Rag1-/-γc-/- (RAG1-Hu) and BLT Mice.

Authors:  Rashida Ginwala; Breanna Caruso; Zafar K Khan; Ajinkya Pattekar; Glen M Chew; Michael J Corley; Ronak Loonawat; Steven Jacobson; Sreesha Sreedhar; Lishomwa C Ndhlovu; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-04       Impact factor: 4.147

2.  Neurological manifestations in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis in the Amazon.

Authors:  G A S Dias; G T Yoshikawa; R V L Koyama; S Fujihara; L C S Martins; R Medeiros; J A S Quaresma; H T Fuzii
Journal:  Spinal Cord       Date:  2015-07-14       Impact factor: 2.772

3.  A 17-Year-Old Boy With Right Face Palsy, Left Leg Weakness, and Lytic Skull-Bone Lesions.

Authors:  Ibukunoluwa C Akinboyo; Genevieve M Crane; Lingling Chen; Ravit Arav-Boger
Journal:  J Pediatric Infect Dis Soc       Date:  2018-12-03       Impact factor: 3.164

4.  Human T-Lymphotropic Virus Type 1-Induced Overexpression of Activated Leukocyte Cell Adhesion Molecule (ALCAM) Facilitates Trafficking of Infected Lymphocytes through the Blood-Brain Barrier.

Authors:  Céline Curis; Florent Percher; Patricia Jeannin; Thomas Montange; Sébastien A Chevalier; Danielle Seilhean; Luis Cartier; Pierre-Olivier Couraud; Olivier Gout; Antoine Gessain; Pierre-Emmanuel Ceccaldi; Philippe V Afonso
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

5.  Identification of dysregulated pathways underlying HTLV-1-associated myelopathy/tropical spastic paraparesis through co-expression network analysis.

Authors:  Mohadeseh Zarei Ghobadi; Sayed-Hamidreza Mozhgani; Yousef Erfani
Journal:  J Neurovirol       Date:  2021-01-06       Impact factor: 2.643

6.  HTLV-1 Tax-mediated inhibition of FOXO3a activity is critical for the persistence of terminally differentiated CD4+ T cells.

Authors:  David Olagnier; Alexandre Sze; Samar Bel Hadj; Cindy Chiang; Courtney Steel; Xiaoying Han; Jean-Pierre Routy; Rongtuan Lin; John Hiscott; Julien van Grevenynghe
Journal:  PLoS Pathog       Date:  2014-12-18       Impact factor: 6.823

Review 7.  HTLV-1, Immune Response and Autoimmunity.

Authors:  Juarez A S Quaresma; Gilberto T Yoshikawa; Roberta V L Koyama; George A S Dias; Satomi Fujihara; Hellen T Fuzii
Journal:  Viruses       Date:  2015-12-24       Impact factor: 5.048

8.  Evaluation of the role of TAX, HBZ, and HTLV-1 proviral load on the survival of ATLL patients.

Authors:  Mohammad Mehdi Akbarin; Abbas Shirdel; Alireza Bari; Seyedeh Tahereh Mohaddes; Houshang Rafatpanah; Ehsan Ghayour Karimani; Kobra Etminani; Amin Golabpour; Reza Torshizi
Journal:  Blood Res       Date:  2017-06-22

9.  Cytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil.

Authors:  João Américo Domingos; Luana Silva Soares; Larissa M Bandeira; Camila Mareti Bonin; Ana C P Vicente; Louise Zanella; Marco Antonio Moreira Puga; Inês Aparecida Tozetti; Ana Rita Coimbra Motta-Castro; Rivaldo Venâncio da Cunha
Journal:  PLoS One       Date:  2017-04-04       Impact factor: 3.240

10.  The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice.

Authors:  Etai Rotem; Omri Faingold; Meital Charni; Yoel A Klug; Daniel Harari; Liraz Shmuel-Galia; Alon Nudelman; Varda Rotter; Yechiel Shai
Journal:  PLoS Pathog       Date:  2018-05-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.